NCCN Issues Guideline Update on the Use of High-Dose Methotrexate, Glucarpidase in ALL/B-Cell Lymphoma

The National Comprehensive Cancer Network has announced a guideline update concerning the treatment of patients with acute lymphoblastic leukemia, B-cell lymphomas, pediatric ALL, and pediatric aggressive mature B-cell lymphoma.

Related Keywords

Ohio ,United States ,Cincinnati ,Laura Ramsey ,National Comprehensive Cancer Network ,Cincinnati Children Hospital Medical Center ,Medical Strategy ,Cincinnati Children ,Hospital Medical Center ,Managing Toxicities ,Clin Pharmacol ,Patients With Newly Diagnosed Acute Lymphocytic Leukemia ,Patients Withb Cell All ,Nccn ,High Dose Methotrexate ,B Cell Lymphomas ,Pediatric All ,Glucarpidase ,